Differential processing and presentation of the H-2Db-restricted epitope from two different strains of influenza virus nucleoprotein

References

1. Antoine G., Scheiflinger F., Dorner F., Falkner F. G. 1998; The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244:365–396
   [Google Scholar]
2. Anton L. C., Yewdell J. W., Bennink J. R. 1997; MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. Journal of Immunology 158:2535–2542
   [Google Scholar]
3. Bennink J. R., Yewdell J. W. 1990; Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function. Current Topics in Microbiology and Immunology 163:153–184
   [Google Scholar]
4. Blake N. W., Kettle S., Law K. M., Gould K., Bastin J., Townsend A. R. M., Smith G. L. 1995; Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes. Journal of General Virology 76:2393–2398
   [Google Scholar]
5. Cerundolo V., Tse A. G. D., Salter R. D., Parham P., Townsend A. 1991; CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68.1. Proceedings of the Royal Society of London Series B Biological Sciences 244:169–177
   [Google Scholar]
6. Cerundolo V., Benham A., Braud V., Mukherjee S., Gould K., Macino B., Neefjes J., Townsend A. 1997; The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. European Journal of Immunology 27:336–341
   [Google Scholar]
7. Chakrabarti S., Brechling K., Moss B. 1985; Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Molecular and Cellular Biology 5:3403–3409
   [Google Scholar]
8. Cossins J., Gould K. G., Smith M., Driscoll P., Brownlee G. G. 1993; Precise prediction of a K^k-restricted cytotoxic T cell epitope within the NS1 protein of influenza virus using an MHC allele-specific motif. Virology 193:289–295
   [Google Scholar]
9. Coupar B. E. H., Andrew M. E., Both G. W., Boyle D. B. 1986; Temporal regulation of influenza haemagglutinin expression in vaccinia virus recombinants and effects on the immune response. European Journal of Immunology 16:1479–1487
   [Google Scholar]
10. Gould K. G., Scotney H., Brownlee G. G. 1991; Characterization of two distinct major histocompatibility complex class I K^k-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin. Journal of Virology 65:5401–5409
    [Google Scholar]
11. Haanen J. B. A. G., Wolkers M. C., Kruisbeek A. M., Schumacher T. N. M. 1999; Selective expansion of cross-reactive CD8⁺ memory T cells by viral variants. Journal of Experimental Medicine 190:1319–1328
    [Google Scholar]
12. Hanke T., Blanchard T. J., Schneider J., Ogg G. S., Tan R., Becker M., Gilbert S. C., Hill A. V. S., Smith G. L., McMichael A. 1998; Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. Journal of General Virology 79:83–90
    [Google Scholar]
13. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., Johnson D. 1995; Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411–415
    [Google Scholar]
14. Miller D. M., Sedmak D. D. 1999; Viral effects on antigen processing. Current Opinion in Immunology 11:94–99
    [Google Scholar]
15. Moss B. 1968; Inhibition of HeLa cell protein synthesis by the vaccinia virion. Journal of Virology 2:1028–1037
    [Google Scholar]
16. Schneider J., Gilbert S. C., Blanchard T. J., Hanke T., Robson K. J., Hannan C. M., Becker M., Sinden R., Smith G. L., Hill A. V. S. 1998; Enhanced immunogenicity for CD8⁺ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nature Medicine 4:397–402
    [Google Scholar]
17. Schubert U., Anton L. C., Gibbs J., Norbury C. C., Yewdell J. W., Bennink J. R. 2000; Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770–774
    [Google Scholar]
18. Smith G. L., Levin J. Z., Palese P., Moss B. 1987; Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology 160:336–345
    [Google Scholar]
19. Smith G. L., Howard S. T., Chan Y. S. 1989; Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors. Journal of General Virology 70:2333–2343
    [Google Scholar]
20. Tourdot S., Oukka M., Manuguerra J. C., Magafa V., Vergnon I., Riche N., Bruley-Rosset M., Cordopatis P., Kosmatopoulos K. 1997; Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity. Journal of Immunology 159:2391–2398
    [Google Scholar]
21. Townsend A. R. M., McMichael A. J., Carter N. P., Huddleston J. A., Brownlee G. G. 1984; Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 39:13–25
    [Google Scholar]
22. Townsend A. R. M., Gotch F. M., Davey J. 1985; Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42:457–467
    [Google Scholar]
23. Townsend A., Bastin J., Gould K., Brownlee G., Andrew M., Coupar B., Boyle D., Chan S., Smith G. 1988; Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. Journal of Experimental Medicine 168:1211–1224
    [Google Scholar]
24. Wiertz E. J. H. J., Jones T. R., Sun L., Bogyo M., Geuze H. J., Ploegh H. L. 1996; The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769–779
    [Google Scholar]